LADENBURG THALMANN FINANCIAL SERVICES INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$72,000
+380.0%
3,015
+480.9%
0.00%
Q3 2019$15,000
-59.5%
519
-54.0%
0.00%
Q2 2019$37,000
-11.9%
1,129
-4.6%
0.00%
Q1 2019$42,000
-10.6%
1,184
-16.7%
0.00%
Q4 2018$47,000
+20.5%
1,421
+85.5%
0.00%
Q3 2018$39,000
-56.7%
766
-60.8%
0.00%
-100.0%
Q2 2018$90,0000.0%1,9550.0%0.00%0.0%
Q1 2018$90,000
+40.6%
1,955
+23.7%
0.00%0.0%
Q4 2017$64,000
-14.7%
1,581
-14.8%
0.00%0.0%
Q3 2017$75,000
-15.7%
1,856
-10.3%
0.00%0.0%
Q2 2017$89,000
+11.2%
2,070
-18.6%
0.00%0.0%
Q1 2017$80,000
+11.1%
2,544
-11.2%
0.00%0.0%
Q4 2016$72,000
+9.1%
2,865
+5.4%
0.00%0.0%
Q3 2016$66,000
-13.2%
2,718
-27.2%
0.00%0.0%
Q2 2016$76,000
+35.7%
3,734
+1.2%
0.00%0.0%
Q1 2016$56,000
+86.7%
3,690
+67.1%
0.00%0.0%
Q4 2015$30,000
-18.9%
2,208
-16.7%
0.00%0.0%
Q3 2015$37,000
-17.8%
2,651
+1.0%
0.00%0.0%
Q2 2015$45,000
+200.0%
2,626
+116.8%
0.00%
Q1 2015$15,000
+50.0%
1,2110.0%0.00%
Q4 2014$10,000
-9.1%
1,2110.0%0.00%
Q3 2014$11,000
-15.4%
1,2110.0%0.00%
Q2 2014$13,000
+44.4%
1,211
+21.1%
0.00%
Q1 2014$9,000
+12.5%
1,0000.0%0.00%
Q4 2013$8,0001,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders